Search Results - "Tosat Bitrian, C."

Theme 05 - Human Cell Biology and Pathology (including iPSC studies).

Authors: Dafinca, R. Tosat Bitrian, C. Scaber, J. et al.

Source: Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. Nov2022 Suppl 1, Vol. 23 Issue 1, p83-98. 16p.

Real-Time and Spatially Resolved Epigenetic Dynamics Tracking Beyond DNA Methylation via Live-Cell Epigenetic Sensors in 3D Systems.

Authors: Tariq, Aqsa Naz, Iram Arshad, Fareeha et al.

Source: Biosensors (2079-6374); Apr2026, Vol. 16 Issue 4, p188, 30p

Quantum dot enhanced photonic biosensors for single cell analysis from synthesis to clinical application.

Authors: Hooshiar, Mohammad Hosseini Hooshiar, Javad Hosseini Hooshiar, Saeed Hosseini

Source: Discover Nano; 2/24/2026, Vol. 21 Issue 1, p1-31, 31p

Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons.

Authors: Dafinca R Tosat-Bitrian C Carroll E et al.

Source: Brain communications [Brain Commun] 2024 Oct 05; Vol. 6 (5), pp. fcae350. Date of Electronic Publication: 2024 Oct 05 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE

TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord.

Authors: Feneberg, Emily Thompson, Alexander G. Charles, Philip D. et al.

Source: Acta Neuropathologica Communications. 8/18/2025, Vol. 13 Issue 1, p1-11. 11p.

Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.

Authors: Kellett, Elise A. Bademosi, Adekunle T. Walker, Adam K.

Source: Molecular Neurodegeneration. 5/8/2025, Vol. 20 Issue 1, p1-35. 35p.

Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.

Authors: Liu, Tian Wetzel, Liam Zhu, Zexi et al.

Source: Cells (2073-4409). Dec2023, Vol. 12 Issue 24, p2781. 18p.

Age-Related Neurodegenerative Diseases: A Stem Cell's Perspective.

Authors: Calvo, Belén Schembri-Wismayer, Pierre Durán-Alonso, María Beatriz

Source: Cells (2073-4409). Mar2025, Vol. 14 Issue 5, p347. 58p.

The ZIKV NS5 Protein Aberrantly Alters the Tubulin Cytoskeleton, Induces the Accumulation of Autophagic p62 and Affects IFN Production: HDAC6 Has Emerged as an Anti-NS5/ZIKV Factor.

Authors: Pérez-Yanes, Silvia Lorenzo-Sánchez, Iria Cabrera-Rodríguez, Romina et al.

Source: Cells (2073-4409). Apr2024, Vol. 13 Issue 7, p598. 27p.

Influence of Inflammatory Cytokines IL-1β and IFNγ on Sarcoplasmic Aggregation of p62 and TDP-43 in Myotubes.

Authors: McCord, Bryony Day, Richard M.

Source: Mediators of Inflammation. 9/12/2023, p1-13. 13p.

A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis.

Authors: Pampalakis, Georgios Angelis, Georgios Zingkou, Eleni et al.

Source: Clinical & Translational Medicine. Jan2022, Vol. 12 Issue 1, p1-24. 24p.

Protein kinase inhibitors for amyotrophic lateral sclerosis therapy.

Authors: Palomo, Valle Nozal, Vanesa Rojas‐Prats, Elisa et al.

Source: British Journal of Pharmacology. Mar2021, Vol. 178 Issue 6, p1316-1335. 20p. 3 Diagrams, 2 Charts.

How Molecular Topology Can Help in Amyotrophic Lateral Sclerosis (ALS) Drug Development: A Revolutionary Paradigm for a Merciless Disease.

Authors: Galvez-Llompart, Maria Zanni, Riccardo Garcia-Domenech, Ramon et al.

Source: Pharmaceuticals (14248247). Jan2022, Vol. 15 Issue 1, p94-94. 1p.

Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS).

Authors: Carroll E Scaber J Pasniceanu IS et al.

Source: Cell death & disease [Cell Death Dis] 2026 Jan 31; Vol. 17 (1), pp. 193. Date of Electronic Publication: 2026 Jan 31.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.

Authors: Martínez-González, Loreto Gonzalo-Consuegra, Claudia Gómez-Almería, Marta et al.

Source: International Journal of Molecular Sciences. Aug2021, Vol. 22 Issue 16, p8975-8975. 1p.

Amyotrophic Lateral Sclerosis: Focus on Cytoplasmic Trafficking and Proteostasis.

Authors: Ms S Banerjee S D'Mello SR et al.

Source: Molecular neurobiology [Mol Neurobiol] 2025 Aug; Vol. 62 (8), pp. 10091-10117. Date of Electronic Publication: 2025 Apr 03.

Publication Type: Journal Article; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE

Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases.

Authors: Huang, Chunhui Yan, Sen Zhang, Zaijun

Source: Translational Neurodegeneration. 10/30/2020, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Investigation of early axonal phenotypes in an iPSC-derived ALS cellular model using a microfluidic device.

Authors: Otomo A Nishijima K Murakami Y et al.

Source: Frontiers in cellular neuroscience [Front Cell Neurosci] 2025 Jul 24; Vol. 19, pp. 1590732. Date of Electronic Publication: 2025 Jul 24 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477935 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5102 (Print) Linking ISSN: 16625102 NLM ISO Abbreviation: Front Cell Neurosci Subsets: PubMed not MEDLINE

TDP-43 as a potential retinal biomarker for neurodegenerative diseases.

Authors: Glashutter M Wijesinghe P Matsubara JA

Source: Frontiers in neuroscience [Front Neurosci] 2025 Feb 12; Vol. 19, pp. 1533045. Date of Electronic Publication: 2025 Feb 12 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE

Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases.

Authors: Chen C Qi J Li Y et al.

Source: Frontiers in neuroscience [Front Neurosci] 2024 Feb 02; Vol. 18, pp. 1301107. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE